Parkinson plus syndrome

Parkinson-plus syndrome is a group of neurodegenerative disorders that share some of the characteristics of Parkinson's disease but also have additional features that distinguish them from classic Parkinson's disease. These syndromes are also known as atypical parkinsonian syndromes. They are characterized by a lack of dopamine in the brain, similar to Parkinson's disease, but they do not respond as well to dopamine replacement therapies. The most common Parkinson-plus syndromes include Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), and Dementia with Lewy Bodies (DLB).

Symptoms

The symptoms of Parkinson-plus syndromes can vary widely depending on the specific disorder but generally include the classic symptoms of Parkinson's disease such as tremor, slowness of movement (bradykinesia), rigidity, and postural instability. In addition, each syndrome has its unique symptoms:

• MSA may present with autonomic dysfunction, cerebellar ataxia, and parkinsonian symptoms.
• PSP is characterized by vertical gaze palsy, frequent falls, and cognitive changes.
• CBD can show asymmetric rigidity, dystonia, and cognitive dysfunction.
• DLB includes significant cognitive impairment, visual hallucinations, and fluctuating alertness.

Diagnosis

Diagnosis of Parkinson-plus syndromes is challenging and primarily based on clinical examination and the presence of additional symptoms not typical of Parkinson's disease. Neuroimaging, such as MRI and PET scans, can help in differentiating these syndromes from classic Parkinson's disease. However, a definitive diagnosis often requires neuropathological examination.

Treatment

There is no cure for Parkinson-plus syndromes, and treatment is primarily symptomatic. Levodopa may offer limited relief for parkinsonian symptoms, but its effectiveness is often reduced or shorter-lived compared to Parkinson's disease. Physical therapy, occupational therapy, and speech therapy can help manage symptoms and improve quality of life. In some cases, medications may be prescribed to manage specific symptoms such as autonomic dysfunction or cognitive impairment.

Prognosis

The prognosis for individuals with Parkinson-plus syndromes varies depending on the specific disorder but is generally considered to be poorer than that of Parkinson's disease. These syndromes tend to progress more rapidly and are associated with significant disability and reduced life expectancy.

See Also

• Neurodegenerative disorders
• Parkinson's disease
• Autonomic dysfunction
• Cerebellar ataxia
• Dystonia

Parkinson plus syndrome Resources
Latest articles Most recent articles Ongoing trials	Wikipedia